Schedule 13G ownership disclosure

CEREVEL THERAPEUTICS HLDNG I

Security class unavailable · CUSIP: 15678U128

Event date: 2020-10-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,637,066
Percent of class
18.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-20-001708
Form type
SC 13G
Filer
Cerevel Therapeutics Holdings, Inc.
CIK
CIK 1805387
Filed
Nov 10, 2020
Reporting period
Oct 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub